针对Rab-RILPL相互作用作为一种降低帕金森病病原性LRRK2调节的策略
Krista K Alexander1, Yahaira Naaldijk2, Rachel Fasiczka2
1Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA, USA.
概括
针对Rab蛋白的新型酸提供了针对家族性帕金森病 (PD) 的新战略. 这些RILPL相互作用 (RIPs) 可能会恢复因突变型白丰富重复蛋白激酶2 (LRRK2) 损害的细胞功能.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 家族性帕金森病 (PD) 经常与氨酸丰富的重复蛋白激酶2 (LRRK2) 的突变有关,导致激酶过活.
- 过度活跃的LRRK2会导致致病性影响,包括纤维生殖缺陷和中枢体凝聚力损失,由化Rab蛋白 (pRabs) 与RILPL因子结合.
研究的目的:
- 通过阻断pRab-RILPL相互作用,研究Rab衍生的基仿真物是否可以抑制LRRK2的致病信号传递.
- 通过准LRRK2的下游作用因子,而不是LRRK2激酶活性本身,开发PD的替代治疗策略.
主要方法:
- 设计和合成的受约束 (RIP),模仿化Rab8开关II.
- 评估了细胞的透性及其与RILPL2结合的能力.
- 在表达突变LRRK2的细胞中,评估了RIP在恢复纤维生成和中枢体凝聚力的有效性.
主要成果:
- 几次RIP证明了细胞透性和结合RILPL2.
- 特定的RIPs成功地恢复了PD相关突变LRRK2的细胞模型中的纤维生成和中枢体凝聚力缺陷.
- 这表明,RIPs可以有效地降低致病性LRRK2信号传输.
结论:
- 限制性 (RIP) 是致病性LRRK2活性的有效下游抑制剂.
- 通过向特定的LRRK2-激活通路,RIPs代表了家族性帕金森病的有希望的替代治疗方法.
相关概念视频
01:24Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
01:15Parkinson's Disease: Overview
554
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
554
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K